What to Expect at
GCP Good Clinical Practice Summit
The Proactive GCP Compliance Conference is the original GCP event, and has provided the industry with valuable education and networking opportunities for more than a decade. This annual gathering of senior-level clinical quality and operations professionals offers like-minded individuals the opportunity to engage with each other and share common challenges and best practices.
A robust agenda built with guidance from our esteemed 2020 Clinical Quality Advisory Board, featuring a diverse faculty of experts from companies of varying type and size, provides participants with a choice of session topics and session types and the ability to design your own agenda and ensure you take away the information, tools, and connections you need to optimize clinical quality at your company.
Who Attends
This conference is designed for professionals from pharmaceutical, biotechnology, and medical device companies; CROs; and other clinical trial service providers whose responsibilities involve the following:
Good Clinical Practice (GCP) |
Compliance/Global Compliance |
Clinical Quality Assurance/Control |
Data Management/System Operations |
Clinical Trial Operations/Management |
Clinical Monitoring |
Clinical Research |
Regulatory Affairs |
Quality/Global Quality Management |
Safety & Risk Management/Operations |
Audits/Inspections |
Participants of GCP Good Clinical Practice Summit
Abbott Laboratories |
Emergent Biosolutions |
Spero Therapeutics |
Abbvie |
Gilead Sciences |
Stoke Therapeutics |
Alexion Pharmaceuticals |
Harbor Clinical |
Sunovion Pharmaceuticals |
Arbutus Biopharma |
Inovio Pharmaceuticals |
Takeda |
Biogen |
Johnson and Johnson |
Tarveda Therapeutics |
Bluebird bio |
Merck |
Ultragenyx |
Bristol-Mysers Squibb |
Novartis |
United Therapeutics |
Clearside Biomedical |
Revance Therapeutics |
GW Pharmaceuticals |
CSL Behring |
Sangamo Therapeutics |
Flexion Therapeutics |
EMD Serono |
Sarepta Therapeutics |
Boehringer Ingelheim |